Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-03-10

Clinical Trial Update: Alvocidib and Oxaliplatin With or Without Fluorouracil and Leucovorin Calcium in Treating Patients With Relapsed or Refractory Germ Cell Tumors [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluated alvocidib plus oxaliplatin with or without fluorouracil and leucovorin calcium in relapsed or refractory germ cell tumors; re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alvocidib (Flavopiridol)
  • FLUOROURACIL (Fluorouracil)
  • Leucovorin calcium (calcium folinate)
  • OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Recurrent Extragonadal Seminoma, Recurrent Malignant Extragonadal Germ Cell Tumor | Phase 2 | Status: COMPLETED | Results posted: 2017-03-10